Common Neoplasms

  • Samuel P. Hammar


Lung cancer is the most frequently diagnosed malignant neoplasm throughout the world. It is the number-one cause of cancer death in the American male, and is responsible for 25% of all cancer deaths in the United States.1 More startling, 5% of all deaths in the United States are caused by lung cancer, a death rate equal to that caused by accidents.1 Since 1930 more people have died from lung cancer than all other types of cancer combined.2 An estimated 150,000 new cases of lung cancer will be diagnosed in the United States in 1987; 99,000 in men and 51,000 in women.3 If trends remain unchanged, 200,000 new cases will occur in the year 2000.4


Small Cell Carcinoma Squamous Carcinoma Atypical Carcinoid Bronchial Carcinoid Bronchioloalveolar Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Jett JR, Cortese DA, Fonatana RS. Lung cancer: current concepts. CA 1983; 33: 74–86.PubMedGoogle Scholar
  2. 2.
    Lung cancer and asbestos related pulmonary disease. A national correspondence course. Park Ridge: American College of Chest Physicians, 1981.Google Scholar
  3. 3.
    Silverberg E, Lubera J. Cancer statistics, 1987. CA 1987; 37: 2–19.PubMedGoogle Scholar
  4. 4.
    Bone RC, Balk R. Staging of bronchogenic carcinoma. Chest 1982; 82: 473–480.PubMedCrossRefGoogle Scholar
  5. 5.
    Robbins SL. The respiratory system. In: Pathologic basis of disease. Philadelphia: Saunders, 1974: 833–840.Google Scholar
  6. 6.
    Galofre M, Payne WS, Woolner LB, Claggett OT, Gage RP. Pathologic classification and surgical treatment of bronchogenic carcinoma. Surg Gynecol Obstet 1964; 119: 51–61.PubMedGoogle Scholar
  7. 7.
    Selawry OS, Hansen HH. Lung cancer. In: Holland JF, Frei E, eds. Cancer medicine. Part 2. Philadelphia: Lea and Febiger, 1973: 1473–1518.Google Scholar
  8. 8.
    Parkin DM, Sternsward J, Muir CS. Estimates of twelve major cancers. Inst WHO 1984; 62: 163–182.Google Scholar
  9. 9.
    Napalkov NP. Incidence of malignant tumors in the USSR between 1970 and 1980. Voprosky Onkologii 1982; 28: 26–27.Google Scholar
  10. 10.
    Stolley PD. Lung cancer: unwanted equality for women. N Engl J Med 1977; 297: 886–887.PubMedCrossRefGoogle Scholar
  11. 11.
    Lung cancer among women. JAMA 1984; 252: 2806 2811.Google Scholar
  12. 12.
    Staryzk PM. Lung-cancer deaths: equality by 2000? N Engl J Med 1983; 309: 1289–1290.Google Scholar
  13. 13.
    Andrews JL, Bloom S, Balogh K, Beamis JF. Lung cancer in women: Lahey clinic experience 1957–1980. Cancer 1985; 55: 2894–2898.PubMedCrossRefGoogle Scholar
  14. 14.
    Anderson AE, Buechner HA, Yoger I, Ziskind MM. Bronchogenic carcinoma in young men. Am J Med 1954; 16: 404–415.PubMedCrossRefGoogle Scholar
  15. 15.
    Neuman HW, Ellis FH, McDonald JR. Bronchogenic carcinoma in persons under forty years of age. N Engl J Med 1956; 254: 502–507.PubMedCrossRefGoogle Scholar
  16. 16.
    Rivkin LM, Salyer JM. Bronchogenic carcinoma in men under 40 years of age. Chest 1958; 34: 521–524.CrossRefGoogle Scholar
  17. 17.
    Hanbury WJ. Bronchogenic carcinoma in young persons. Br J Cancer 1958; 12: 202–206.PubMedCrossRefGoogle Scholar
  18. 18.
    Large SE, Morgan WKC. Bronchial carcinoma in young adults. Br J Tuberc 1958; 52: 185–189.CrossRefGoogle Scholar
  19. 19.
    Hood RH, Campbell DC, Dooley BN. Bronchogenic carcinoma in young people. Dis Chest 1965; 48: 469–470.PubMedCrossRefGoogle Scholar
  20. 20.
    Kennedy A. Lung cancer in young adults. Br J Dis Chest 1972; 66: 147–154.PubMedCrossRefGoogle Scholar
  21. 21.
    Kyniakos M, Webber B. Cancer of the lung in young men. J Thorac Cardiovasc Surg 1974; 67: 634–648.Google Scholar
  22. 22.
    Putnam JS. Lung carcinoma in young adults. JAMA 1977; 238: 35–36.PubMedCrossRefGoogle Scholar
  23. 23.
    Ganz PA, Vernon SE, Preston D, Coulson WF. Lung cancer in younger patients. West J Med 1980; 133: 373–378.PubMedGoogle Scholar
  24. 24.
    DeCaro L, Benfield JR. Lung cancer in young persons. J Thorac Cardiovasc Surg 1982; 83: 372–376.PubMedGoogle Scholar
  25. 25.
    Roviaro GC, Varoli F, Zannini P, Fascianella A, Pezzuoli G. Lung cancer in the young. Chest 1985; 87: 456–459.PubMedCrossRefGoogle Scholar
  26. 26.
    Fielding JE. Smoking: health effects and control. N Engl J Med 1985;313: 491–498, 555–561.Google Scholar
  27. 27.
    Kabat GC, Wynder EL. Lung cancer in nonsmokers. Cancer 1984; 53: 1214–1221.PubMedCrossRefGoogle Scholar
  28. 28.
    Ochsner A, DeBakey M. Carcinoma of the lung. Arch Surg 1941; 42: 209–258.CrossRefGoogle Scholar
  29. 29.
    Wynder EL, Graham EA. Tobacco smoking as a possible etiologic factor in bronchogenic carcinoma. A study of six hundred and eighty four proved cases. JAMA 1950; 143: 329–336.CrossRefGoogle Scholar
  30. 30.
    Hammond EC, Horn D. Smoking and death rates: report on forty-four months of follow-up of 187,783 men. JAMA 1958; 166: 1294–1308.CrossRefGoogle Scholar
  31. 31.
    Rogot E, Murray JL. Smoking and cause of death among American veterans: 16 years of observation. Public Health Rep 1980; 3: 213–222.Google Scholar
  32. 32.
    Pollin W, Ravenholt RT. Tobacco addiction and tobacco mortality. JAMA 1984; 252: 2849–2854.PubMedCrossRefGoogle Scholar
  33. 33.
    Peto R, Doll R. Mortality in relation to smoking: 20 years’ observations on male British doctors. Br Med J 1976; 1525–1536.Google Scholar
  34. 34.
    Guyatt GH, Newhouse MT. Are active and passive smoking harmful? Determining causation. Chest 1985; 88: 445–451.PubMedCrossRefGoogle Scholar
  35. 35.
    Hirayama T Nonsmoking wives of heavy smokers have a higher risk of lung cancer: a study from Japan. Br Med J 1981;282:183–185.Google Scholar
  36. 36.
    Weiss ST. Passive smoking and lung cancer: what is the risk? Am Rev Respir Dis 1986; 133: 1–3.PubMedGoogle Scholar
  37. 36a.
    Trichopoulos D, Delandidi A, Spanos L, MacMahon B. Lung cancer and passive smoking. Int J Cancer 1981; 27: 1–4.PubMedCrossRefGoogle Scholar
  38. 36b.
    Trichopoulos D, Kelandidi A, Spanos L. Lung cancer and passive smoking, conclusion of Greek study. Lancet 1983; 2: 677–678.PubMedCrossRefGoogle Scholar
  39. 36c.
    Garfinkle L, Auerbach O, Joubert L. Involuntary smoking and lung cancer: a case-control study. J Natl Cancer Inst 1985; 75: 463–469.Google Scholar
  40. 36d.
    Hirayama T. Passive smoking and lung cancer. Br Med J 1981; 282: 1393–1394.CrossRefGoogle Scholar
  41. 36e.
    Hirayama T. Passive smoking and lung cancer: consistency of association. Lancet 1983; 2: 145–146.Google Scholar
  42. 36f.
    Garfinkle L. Time trends in lung cancer mortality among nonsmokers and a note on passive smoking. J Natl Cancer Inst 1981; 66: 1061–1066.Google Scholar
  43. 36g.
    Gillis CR, Hale DJ, Hawthorne VM, Boyle P. The effect of environmental tobacco smoke in two urban communities in the West of Scotland. Eur J Respir Dis 1984; 65 (suppl 133): 121–126.Google Scholar
  44. 36h.
    Correa P, Pickle LW, Forham E, Lin Y, Haenszel W. Passive smoking and lung cancer. Lancet 1983; 2: 595–597.PubMedCrossRefGoogle Scholar
  45. 36i.
    Kabat GC, Wynder EL. Lung cancer in nonsmokers. Cancer 1984; 53: 1214–1221.PubMedCrossRefGoogle Scholar
  46. 36j.
    Sandler DP, Everson RB, Wilcox AJ. Passive smoking in adulthood and cancer risk. Am J Epidemiol 1985; 121: 37–48.PubMedGoogle Scholar
  47. 36k.
    Sandler DP, Wilcox AJ, Everson RB. Cumulative effects of lifetime passive smoking on cancer risk. Lancet 1985; 1: 312–314.PubMedCrossRefGoogle Scholar
  48. 361.
    Chan WC, Colbourne MJ, Fung SC, Ho HC. Bronchial cancer in Hong Kong 1976–1977. Br J Cancer 1979: 39: 182–192.PubMedCrossRefGoogle Scholar
  49. 36m.
    Knoth A, Bohn W, Schmidt F. Passive smoking as a causal factor for bronchial carcinoma in female nonsmokers. Med Klin 1983; 78: 66–69.Google Scholar
  50. 36n.
    Koo LC, Ho HC, Saw D. Active and passive smoking among female lung cancer patients and contacts in Hong Kong. J Exp Clin Cancer Res 1983; 4: 367–375.Google Scholar
  51. 37.
    Feyerbend C, Higenbottam T, Russell MAH. Nicotine concentrations in urine and saliva of smokers and nonsmokers. Br Med J 1982; 284: 1002–1004.CrossRefGoogle Scholar
  52. 38.
    Greenberg RA, Haley NJ, Etzel RA, Loda FA. Measuring the exposure of infants to tobacco smoke: nicotine and continine in urine and saliva. N Engl J Med 1984; 310: 1075–1078.PubMedCrossRefGoogle Scholar
  53. 39.
    Kozlowski LT. Tar and nicotine delivery of cigarettes. What a difference a puff makes. JAMA 1981; 245: 158–159.PubMedCrossRefGoogle Scholar
  54. 40.
    Benowitz NL, Hall SM, Herning RI, Jacobs P III, Jones RT, Osman AL. Smokers of low-yield cigarettes do not consume less nicotine. N Engl J Med 1983; 309: 139–142.PubMedCrossRefGoogle Scholar
  55. 41.
    Auerbach O, Hammond EC, Garfinkel L. Changes in bronchial epithelium in relation to cigarette smoking, 1955–1960 vs. 1970–1977. N Engl J Med 1979; 300: 381–386.PubMedCrossRefGoogle Scholar
  56. 42.
    Lee PN, Garfinkel L. Mortality and type of cigarette smoked. J Epidemiol Community Health 1981; 35: 16–22.PubMedCrossRefGoogle Scholar
  57. 43.
    Winters TH, DiFranza JR. Radioactivity in cigarette smoke. N Engl J Med 1982; 306: 364–365.PubMedGoogle Scholar
  58. 44.
    Martell EA. Radioactivity in cigarette smoke. N Engl J Med 1982; 307: 309–310.CrossRefGoogle Scholar
  59. 45.
    Cohen JI. Radioactivity in cigarette smoke. N Engl J Med 1982; 307: 310.Google Scholar
  60. 46.
    Cohen BS, Harley NH. Radioactivity in cigarette smoke. N Engl J Med 1982; 307: 309–310.CrossRefGoogle Scholar
  61. 47.
    Hill CR. Radioactivity in cigarette smoke. N Engl J Med 1982; 307: 311.Google Scholar
  62. 48.
    Wagner WL. Radioactivity in cigarette smoke. N Engl J Med 1982; 307: 311.Google Scholar
  63. 49.
    Ravenholt RT. Radioactivity in cigarette smoke. N Engl J Med 1982; 307: 312.Google Scholar
  64. 50.
    Hoffman D, Wynder EL. Radioactivity in cigarette smoke. N Engl J Med 1982; 307: 312.CrossRefGoogle Scholar
  65. 51.
    Gottlieb LS, Husen LA. Lung cancer among Navajo uranium miners. Chest 1982; 81: 449–452.PubMedCrossRefGoogle Scholar
  66. 52.
    Samet JM, Kutvirt DM, Waxweiler RJ, Key CR. Uranium mining and lung cancer in Navajo men. N Engl J Med 1984; 310: 1481–1484.PubMedCrossRefGoogle Scholar
  67. 53.
    Radford EP, St Clair Renard KG. Lung cancer in Swedish iron miners exposed to low doses of radon daughters. N Engl J Med 1984; 310: 1485–1494.PubMedCrossRefGoogle Scholar
  68. 54.
    Radford EP. Radon daughters in the induction of lung cancer in underground miners. In: Peto R, Schneiderman M, eds. Quantification of occupational cancer. Cold Spring Harbor, New York: Cold Spring Laboratory, 1981: 151–163.Google Scholar
  69. 55.
    Thomas DC, McNeill KG. Risk estimates for the health effects of alpha radiation. Ottawa: Report to the Canadian Atomic Energy Control Board, 1982.Google Scholar
  70. 56.
    The Seattle Times, Sunday, Sept 8, 1985.Google Scholar
  71. 57.
    Indoor air pollution. If you think your home is a bastion of clean air in a polluted world, think again. Consumer Reports 1985; 50: 600–603.Google Scholar
  72. 58.
    Vena JE, Byers TE, Cookfair D, Swanson M. Occupation and lung cancer risk. An analysis by histologic subtypes. Cancer 1985; 56: 910–917.PubMedCrossRefGoogle Scholar
  73. 59.
    Saracci R. Asbestos and lung cancer: an analysis of the epidemiological evidence on the asbestos-smoking interaction. Int J Cancer 1977; 20: 323–331.PubMedCrossRefGoogle Scholar
  74. 60.
    Hammond EC, Selikoff IJ, Seidman H. Asbestos exposure, cigarette smoking and death rates. Ann NY Acad Sci 1979; 330: 473–490.PubMedCrossRefGoogle Scholar
  75. 61.
    Selikoff IJ, Hammond EC, Churg J. Asbestos exposure, smoking and neoplasia. JAMA 1968; 204: 106–112.PubMedCrossRefGoogle Scholar
  76. 62.
    Selikoff IJ. Asbestos and smoking. JAMA 1979; 242: 458–459.PubMedCrossRefGoogle Scholar
  77. 63.
    Sluis-Cremer GK. The relationship between asbestosis and bronchial cancer. Chest 1980; 78 (suppl): 380–381.PubMedGoogle Scholar
  78. 64.
    Browne K. Is asbestos or asbestosis the cause of the increased risk of lung cancer in asbestos workers? Br J Ind Med 1986; 43: 145–149.PubMedGoogle Scholar
  79. 65.
    Warnock ML, Churg AM. Association of asbestos and bronchogenic carcinoma in a population with low asbestos exposure. Cancer 1975; 35: 1236–1242.PubMedCrossRefGoogle Scholar
  80. 66.
    Warnock ML, Kuwahara TJ, Wolery G. The relation of asbestos burden to asbestosis and lung cancer. Path Annu 1983; 18 (Part 2): 109–145.Google Scholar
  81. 67.
    Warnock ML, Isenberg W. Asbestos burden and the pathology of lung cancer. Chest 1986; 89: 20–26.PubMedCrossRefGoogle Scholar
  82. 68.
    Wagner JC, Berry G, Skidmore JW, Timbrell V. The effects of the inhalation of asbestos in rats. Br J Cancer 1974; 29: 252–269.PubMedCrossRefGoogle Scholar
  83. 69.
    Browne K. A threshold for asbestos-related lung cancer. Br J Ind Med 1986; 43: 556–558.PubMedGoogle Scholar
  84. 70.
    McFadden D, Wright JL, Wiggs B, Churg A. Smoking inhibits asbestos clearance. Am Rev Respir Dis 1986; 133: 372–374.PubMedGoogle Scholar
  85. 71.
    McFadden D, Wright J, Wiggs B, Churg A. Cigarette smoke increase the penetration of asbestos fibers into airway walls. Am J Pathol 1986; 123: 95–99.PubMedGoogle Scholar
  86. 72.
    Mossman BT, Cameron GS, Yotti LP. Cocarcinogenic and tumor promoting properties of asbestos and other minerals in tracheobronchial epithelium. In: Mass MJ, et al., eds. Carcinogenesis. New York: Raven Press, 1985: 217–238.Google Scholar
  87. 73.
    Edge JR. Incidence of bronchial carcinoma in shipyard workers with pleural plaques. Ann NY Acad Sci 1979; 330: 330: 289–294.PubMedCrossRefGoogle Scholar
  88. 74.
    Kivilvoto R, Meurman LO, Hakama M. Pleural plaques and neoplasia in Finland. Ann NY Acad Sci 1979; 330: 31–33.CrossRefGoogle Scholar
  89. 75.
    Ives JC, Buffler PA, Greenberg SD. Environmental association and histopathologic patterns of carcinoma of the lung: the challenge and dilemma in epidemiologic studies. Am Rev Respir Dis 1983; 128: 195–209.PubMedGoogle Scholar
  90. 76.
    Churg A. Lung cancer cell type and asbestos exposure. JAMA 1985; 253: 2984–2985.PubMedCrossRefGoogle Scholar
  91. 77.
    Auerbach O, Garfinkel L, Parks VR, Conston AS, Galdi VA, Joubert L. Histologic type of lung cancer and asbestos exposure. Cancer 1984; 54: 3017–302.PubMedCrossRefGoogle Scholar
  92. 78.
    Barton RTH, Hogetveit ACH. Nickel-related cancers of the respiratory tract. Cancer 1980; 45: 3061–3064.PubMedCrossRefGoogle Scholar
  93. 79.
    Wicks MH, Archer VE, Auerbach O, Kuschner M. Arsenic exposure in a copper smelter as related to histological type of lung cancer. Am J Ind Med 1981; 2: 25–31.PubMedCrossRefGoogle Scholar
  94. 80.
    Smith AB, Suzuki Y. Histopathologic classification of bronchogenic carcinomas among a cohort of workers occupationally exposed to beryllium. Environ Res 1980; 21: 10–14.PubMedCrossRefGoogle Scholar
  95. 81.
    Osburn HS. Lung cancer in a mining district in Rhodesia. S Afr Med J 1969; 43: 1307–1312.PubMedGoogle Scholar
  96. 82.
    National Academy of Sciences. Committee on biologic effects of atmospheric pollutants. Chromium. Washington DC: Division of Medical Sciences, National Research Council, 1974: 58.Google Scholar
  97. 83.
    Figueroa WG, Raszkowki R, Weiss W. Lung cancer in chloromethyl methyl ether workers. N Engl J Med 1973; 288: 1096–1097.PubMedCrossRefGoogle Scholar
  98. 84.
    Wasweiler RJ, Smith AH, Falk H, Tyroler HA. Excess lung cancer risk in a synthetic chemicals plant. Environ Health Perspect 1981; 41: 159–165.CrossRefGoogle Scholar
  99. 85.
    Aksoy M. Different types of malignancies due to occupational exposure to benzene: a review of recent observations in Turkey. Environ Res 1980; 23: 181–190.PubMedCrossRefGoogle Scholar
  100. 86.
    Yamada A. On the late injuries following occupational inhalation of mustard gas with special references to carcinoma of the respiratory tract. Acta Pathol Jpn 1963; 13: 131–155.PubMedGoogle Scholar
  101. 87.
    Markman M, Braine HG, Abeloff MD. Histocompatibility antigens in small cell carcinoma of the lung. Cancer 1984; 54: 2943–2945.PubMedCrossRefGoogle Scholar
  102. 88.
    Whang-Peng J, Kao-Shan CS, Bunn PA, Carney DN, Gazdar AF, Minna JD. Specific chromosome defect associated with human small-cell lung cancer: deletion 3p(14–23). Science 1982; 215: 181–182.PubMedCrossRefGoogle Scholar
  103. 89.
    Samet JM, Skipper BJ, Humble CG, Pathak DR. Lung cancer risk and vitamin A consumption in New Mexico. Am Rev Respir Dis 1985; 131: 198–202.PubMedGoogle Scholar
  104. 90.
    Weiss W, Seidman H, Boucot K. The Philadelphia pulmonary neoplasm research project: thwarting factors in periodic screening for lung cancer. Am Rev Respir Dis 1975; 111: 289–297.PubMedGoogle Scholar
  105. 91.
    Nash FA, Morgan JM, Tomkins JG. South London cancer study. Br Med J 1968; 2: 715–721.PubMedCrossRefGoogle Scholar
  106. 92.
    ACS report on the cancer-related checkup: cancer of the lung; Appendix B: experimental biases. CA 1980;30:199–207.Google Scholar
  107. 93.
    Brett GZ. Earlier diagnosis and survival in lung cancer. Br Med J 1969; 4: 260–262.PubMedCrossRefGoogle Scholar
  108. 94.
    Frost JK, Ball WC, Levin ML, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am Rev Respir Dis 1984; 130: 549–554.PubMedGoogle Scholar
  109. 95.
    Flehinger BJ, Melamed MR, Zaman MB, Heelan RT, Perchick WB, Martini N. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Memorial Sloan-Kettering study. Am Rev Respir Dis 1984; 130: 555–560.PubMedGoogle Scholar
  110. 96.
    Fontana RS, Sanderson DR, Taylor WF, et al. Early lung cancer detection: results of the initial (prevlance) radiologic and cytologic screening in the Mayo Clinic study. Am Rev Respir Dis 1984; 130: 561–565.PubMedGoogle Scholar
  111. 97.
    Bailar JC. Screening for lung cancer-where are we now? Am Rev Respir Dis 1984; 130: 541–542.PubMedGoogle Scholar
  112. 98.
    Weiss W. Screening for lung cancer. Chest 1985; 87: 273–274.PubMedCrossRefGoogle Scholar
  113. 99.
    Merz B. Is screening for early lung cancer worthwhile? JAMA 1983; 249: 1537–1538.PubMedCrossRefGoogle Scholar
  114. 100.
    Dreis DF. Screening for lung cancer: do chest x:rays save lives or waste money? Bull Mason Clin 1985; 39: 113–121.Google Scholar
  115. 101.
    Feld R, Rubinstein LV, WeisenbergerTH, and the Lung Cancer Study Group. Sites of recurrence in resected stage 1 non-small cell lung cancer: a guide for future studies. J Clin Oncol 1984; 2: 1352–1358.Google Scholar
  116. 102.
    Li W, Hammar SP, Jolly PC, Hill LD, Anderson RP. Unpredictable course of small cell undifferentiated lung carcinoma. J Thorac Cardiovasc Surg 1981; 81: 34–43.PubMedGoogle Scholar
  117. 103.
    Carr DT, Mountain CF. Staging of lung cancer. Semin Respir Med 1982; 3: 154–163.CrossRefGoogle Scholar
  118. 104.
    Naruke T, Suemasu K, Ishikawa S. Lymph node map ping and curability at various levels of metastatis in resected lung cancer. J Thorac Cardiovasc Surg 1978; 76: 832–839.PubMedGoogle Scholar
  119. 105.
    Mountain CF. A new international staging system for lung cancer. Chest 1986; 89 (suppl): 225S - 2335.PubMedGoogle Scholar
  120. 106.
    Tisi GM, Friedman PJ, Peters RM, et al. Clinical staging of primary lung cancer. Am Rev Respir Dis 1983; 127: 659–664.Google Scholar
  121. 107.
    Decker DA, Dines DE, Payne WS, et al. The significance of a cytologically negative pleural effusion in bronchogenic carcinoma. Chest 1978; 74: 640–642.PubMedCrossRefGoogle Scholar
  122. 108.
    Grillo HC. Carinal reconstruction. Ann Thorac Surg 1982; 34: 356–373.PubMedCrossRefGoogle Scholar
  123. 109.
    Sartori F. Right upper tracheal sleeve lobectomy for carcinoma of the lung. Reconstruction of tracheal bifurcation. Minerva Chir 1984; 39: 209–212.PubMedGoogle Scholar
  124. 110.
    Gilbert A, Deslauriers J, McLish A, Piraux M. Tracheal sleeve pneumonectomy for carcinoma of the proximal left main bronchus. Can J Surg 1984; 27: 583–585.PubMedGoogle Scholar
  125. 111.
    The World Health Organization histological typing of lung tumors. 2d ed. Am J Clin Pathol 1982;77:123–136.Google Scholar
  126. 112.
    Yesner R. Spectrum of lung cancer and ectopic hormones. Pathol Annu 1978; 13 (Part 1): 217–240.Google Scholar
  127. 113.
    Adelstein DJ, Tomahefski JF, Snow NJ, Horrigan JP, Hines JD. Mixed small cell and non-small cell lung cancer. Chest 1986; 89: 699–704.PubMedCrossRefGoogle Scholar
  128. 114.
    Roggli VL, Volmer RT, Greenberg SD, McGavran MH, Spjut HJ, Yesner R. Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases. Hum Pathol 1985; 16: 569–579.PubMedCrossRefGoogle Scholar
  129. 115.
    Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg 1975; 70: 606–612.PubMedGoogle Scholar
  130. 116.
    Razzuk MA, Pockey M, Urschel HC, Paulson DL. Dual primary bronchogenic carcinoma. Ann Thorac Surg 1974; 17: 425–433.PubMedCrossRefGoogle Scholar
  131. 117.
    Rohwedder JJ, Weatherbee L. Multiple primary bronchogenic carcinoma. Ann Thorac Surg 1974; 17: 425–433.CrossRefGoogle Scholar
  132. 118.
    Warren S, Gates O. Multiple primary malignant tumors: a survey of the literature and a statistical study. Am J Cancer 1932; 16: 1358–1414.Google Scholar
  133. 119.
    Auerbach O, Stout AP, Hammond EC, Garfinkel L. Multiple primary bronchial carcinomas. Cancer 1967; 20: 699–705.PubMedCrossRefGoogle Scholar
  134. 120.
    Struve-Christensen E. Diagnosis and treatment of bilateral primary bronchogenic carcinoma. J Thorac Cardiovasc Surg 1971; 61: 501–513.PubMedGoogle Scholar
  135. 121.
    Jung-Legg Y, McGowan SF, Sweeney KG, Zitzman JL, Pugntch RP. Synchronous triple malignant tumors of the lung: a case report of bronchial carcinoid, small cell carcinoma, and adenocarcinoma of the right lung. Am J Clin Pathol 1986; 85: 96–101.PubMedGoogle Scholar
  136. 122.
    Seydel HG, Chait A, Gmelich JT. The natural history of cancer of the lung. In: Seydel HG, Chait A, Gmelich JT, eds. Cancer of the lung. New York: Wiley, 1975: 52–63.Google Scholar
  137. 123.
    Auerbach O. Natural history of carcinoma of the lung. In: Fishman AP, ed. Pulmonary diseases and disorders. New York: McGraw-Hill, 1980: 1388–1396.Google Scholar
  138. 124.
    Byrd RB, Miller WE, Can DT. The roentgenographic appearance of squamous cell carcinoma of the bronchus. Mayo Clin Proc 1968; 43: 327–332.PubMedGoogle Scholar
  139. 125.
    Walter JB, Pryce DM. The site of origin of lung cancer and its relation to histological type. Thorax 1955; 10: 117–126.PubMedCrossRefGoogle Scholar
  140. 126.
    Chaudhuri MR. Primary pulmonary cavitating carcinomas. Thorax 1973; 28: 354–366.PubMedCrossRefGoogle Scholar
  141. 127.
    Dulmet-Brender E, Jaubert F, Huchon G. Exophytic endobronchial epidermoid carcinoma. Cancer 1986; 57: 1358–1364.PubMedCrossRefGoogle Scholar
  142. 128.
    Carter D, Eggleston JC. Squamous cell carcinoma. In: Tumors of the lower respiratory tract (atlas of tumor pathology, 2d ser., fasc. 17 ). Washington DC: Armed Forces Institute of Pathology 1980: 70–94.Google Scholar
  143. 129.
    Trump BF, McDowell EM, Glavin F, et al. The respiratory epithelium. III. Histogenesis of epidermoid metaplasia and carcinoma in situ in the human. J Natl Cancer Inst 1978; 61: 563–575.PubMedGoogle Scholar
  144. 130.
    Yamamoto M, Shimokata K, Nagura H. Immunoelectron microscopic study on the histogenesis of epidermoid metaplasia in respiratory epithelium. Am Rev Respir Dis 1987; 135: 713–718.PubMedGoogle Scholar
  145. 131.
    Vincent RG, Pickren JW, Lane WW, et al. The changing histopathology of lung cancer: a review of 1682 cases. Cancer 1977; 39: 1647–1655.PubMedCrossRefGoogle Scholar
  146. 132.
    Valaitis J, Warren S, Gamble D. Increasing incidence of adenocarcinoma of the lung. Cancer 1981; 47: 1042–1046.PubMedCrossRefGoogle Scholar
  147. 133.
    Taylor AB, Shinton NH, Waterhouse JAH. Histology of bronchial carcinoma in relation to prognosis. Thorax 1963; 18: 178–181.PubMedCrossRefGoogle Scholar
  148. 134.
    Weiss W, Boucot KR, Cooper DA. The histopathology of bronchogenic carcinoma and its relation to growth rate, metastasis, and prognosis. Cancer 1970; 26: 965970.Google Scholar
  149. 135.
    Ashley DJB, Davies HD. Cancer of the lung: histology and biological behaviour. Cancer 1967; 20: 165–174.PubMedCrossRefGoogle Scholar
  150. 136.
    Bennett DE, Sasser WR, Ferguson TB. Adenocarcinoma of the lung in men: a clinicopathologic study of 100 cases. Cancer 1969; 23: 431–439.PubMedCrossRefGoogle Scholar
  151. 137.
    Raeburn C, Spencer H. A study of the origin and development of lung cancer. Thorax 1953; 8: 1–10.PubMedCrossRefGoogle Scholar
  152. 138.
    Raeburn C, Spencer H. Lung scar cancers. Br J Tuberc Dis Chest 1957; 51: 237–245.PubMedCrossRefGoogle Scholar
  153. 139.
    Carroll R. Influence of lung scars on primary lung cancer. J Pathol Bacteriol 1962; 83: 293–297.PubMedCrossRefGoogle Scholar
  154. 140.
    Auerbach O, Garfinkel L, Parks VR. Scar cancer of the lung: increase over a 21-year period. Cancer 1979; 43: 636–642.PubMedCrossRefGoogle Scholar
  155. 141.
    Scannell JG. “Bleb” carcinoma of the lung. J Thorac Cardiovasc Surg 1980;80:904–908.Google Scholar
  156. 142.
    Konwaler BE, Reingold IM. Carcinoma arising in bronchiectatic cavities. Cancer 1952; 5: 525–529.PubMedCrossRefGoogle Scholar
  157. 143.
    Shimosato Y, Hashimoto T, Kodama T, et al. Prognostic implications of fibrotic focus (scar) in small peripheral lung cancers. Am J Surg Pathol 1980; 4: 365–373.PubMedCrossRefGoogle Scholar
  158. 144.
    Madri JA, Carter D. Scar cancers of the lung: origin and significance. Hum Pathol 1984; 15: 625–631.PubMedCrossRefGoogle Scholar
  159. 145.
    Kung ITM, Lui IOL, Loke SL, et al. Pulmonary scar cancer: a pathologic reappraisal. Am J Surg Pathol 1985; 9: 391–400.PubMedCrossRefGoogle Scholar
  160. 146.
    Cagle PT, Cohle SD, Greenberg SD. Natural history of pulmonary scar cancers: clinical and pathologic implications. Cancer 1985; 56: 2031–2035.PubMedCrossRefGoogle Scholar
  161. 147.
    Barsky SH, Huang SJ, Bhuta S. The extracellular matrix of pulmonary scar carcinomas is suggestive of a desmoplastic origin. Am J Pathol 1986; 124: 412–419.PubMedGoogle Scholar
  162. 148.
    Meyer EC, Liebow AA. Relationship of interstitial pneumonia honeycombing and atypical epithelial proliferation to cancer of the lung. Cancer 1965; 218: 322–351.CrossRefGoogle Scholar
  163. 149.
    Fox B, Ridson RA. Carcinoma of the lung and diffuse interstitial pulmonary fibrosis. J Clin Pathol 1968; 21: 486–491.PubMedCrossRefGoogle Scholar
  164. 150.
    Haddad R, Massaro D. Idiopathic diffuse interstitial pulmonary fibrosis (fibrosing alveolitis), atypical epithelial proliferation and lung cancer. Am J Med 1968; 45: 211–219.PubMedCrossRefGoogle Scholar
  165. 151.
    Fraire AE, Greenberg SD. Carcinoma and diffuse interstitial fibrosis of lung. Cancer 1973; 31: 1078–1086.PubMedCrossRefGoogle Scholar
  166. 152.
    Turner-Warwick M, Lebowitz M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis and lung cancer. Thorax 1980; 35: 496–499.PubMedCrossRefGoogle Scholar
  167. 153.
    Zatuchni J, Campbell WN, Zarafonetis CJD. Pulmonary fibrosis and terminal bronchiolar (‘alveolar cell’) carcinoma in scleroderma. Cancer 1953; 6: 1147–1158.PubMedCrossRefGoogle Scholar
  168. 154.
    Collins DH, Darke CS, Dodge OG. Scleroderma with honeycomb lung and bronchiolar carcinoma. J Pathol Bacteriol 1958; 76: 531–540.PubMedCrossRefGoogle Scholar
  169. 155.
    Caplan H. Honeycomb lungs and malignant pulmonary adenomatosis in scleroderma. Thorax 1959; 14: 89–96.PubMedCrossRefGoogle Scholar
  170. 156.
    Montgomery RD, Stirling GA, Hamer NAJ. Bronchiolar carcinoma in progressive systemic sclerosis. Lancet 1962; 2: 693–695.Google Scholar
  171. 157.
    Liebow AA. Bronchiolo-alveolar carcinoma. Adv Intern Med 1960; 10: 329–358.PubMedGoogle Scholar
  172. 158.
    Rosenblatt MB, Lisa JR, Collier F. Primary and metastatic bronchiolo-alveolar carcinoma. Dis Chest 1967; 52: 147–152.PubMedCrossRefGoogle Scholar
  173. 159.
    Adamson JS, Senior RM, Merrill T. Alveolar cell carcinoma: an electron microscopic study. Am Rev Respir Dis 1969; 100: 550–557.PubMedGoogle Scholar
  174. 160.
    Coalson JJ, Mohr JA, Pirtle JK, Dee AL, Rhoades ER. Electron microscopy of neoplasms in the lung with special emphasis on the alveolar cell carcinoma. Am Rev Respir Dis 1970; 101: 181–197.PubMedGoogle Scholar
  175. 161.
    Kuhn C. Fine structure of bronchiolo-alveolar cell carcinoma. Cancer 1972; 30: 1107–1118.PubMedCrossRefGoogle Scholar
  176. 162.
    Nash G, Langlinais PC, Greenwald KA. Alveolar cell carcinoma: does it exist? Cancer 1972; 29: 322–326.PubMedCrossRefGoogle Scholar
  177. 163.
    Bedrossian CWM, Weilbaecher DG, Bentinck DC, Greenberg SD. Ultrastructure of human bronchiolo-alveolar cell carcinoma. Cancer 1975; 36: 1399–1413.PubMedCrossRefGoogle Scholar
  178. 164.
    Bonikos DS, Hendrickson M, Bensch KG. Pulmonary alveolar cell carcinoma. Fine structural and in vitro study of a case and critical review of this entity. Am J Surg Pathol 1977; 1: 93–108.PubMedCrossRefGoogle Scholar
  179. 165.
    Sidhu GS, Forrester EM. Glycogen-rich Clara cell-type bronchiolo-alveolar cell carcinoma. Light and electron microscopic study. Cancer 1977; 40: 2209–2215.PubMedCrossRefGoogle Scholar
  180. 166.
    Kimula Y. A histochemical and ultrastructural study of adenocarcinoma of the lung. Am J Surg Pathol 1978; 2: 253–264.PubMedCrossRefGoogle Scholar
  181. 167.
    Morningstar WA, Hassan MO. Bronchiolo-alveolar cell carcinoma with nodal metastases. Am J Surg Pathol 1979; 3: 273–278.PubMedCrossRefGoogle Scholar
  182. 168.
    Carter D, Eggleston JC. Bronchioloalveolar carcinoma. In: Tumors of the lower respiratory tract (atlas of tumor pathology, 2d ser., fasc. 17 ). Washington DC: Armed Forces Institute of Pathology, 1980: 127–147.Google Scholar
  183. 169.
    Hammar SP, Bolen JW, Bockus D, Remington F, Friedman S. Ultrastructural and immunohistochemical features of common lung tumors: an overview. Ultrastruct Pathol 1985; 9: 283–318.PubMedCrossRefGoogle Scholar
  184. 170.
    Clayton F. Bronchioloalveolar carcinomas: cell types„ patterns of growth, and prognostic correlates. Cancer 1986; 57: 1555–1564.PubMedCrossRefGoogle Scholar
  185. 171.
    Herrera GA, Alexander CB, deMoraes HP. Ultrastructural subtypes of pulmonary adenocarcinoma. Correlation with patient survival. Chest 1983; 84: 581–586.PubMedCrossRefGoogle Scholar
  186. 172.
    Torikata C, Ishiwata K. Intranuclear tubular structures observed in the cells of alveolar cell carcinomas of the lung. Cancer 1977; 40: 1194–1201.PubMedCrossRefGoogle Scholar
  187. 173.
    Singh G, Katyal SL, Torikata C. Carcinoma of type II pneumocytes: immunodiagnosis of a subtype of bronchioloalveolar carcinoma. Am J Pathol 1981; 102: 195–208.PubMedGoogle Scholar
  188. 174.
    Singh G, Katyal SL, Torikata C. Carcinoma of type II pneumocytes: PAS staining as a screening test for nuclear inclusions of surfactant-specific appoprotein. Cancer 1982; 50: 946–948.PubMedCrossRefGoogle Scholar
  189. 175.
    Ghadially FN, Harawi S, Khan W. Diagnostic ultrastructural markers in alveolar cell carcinoma. J Submicrosc Cytol 1985; 17: 269–278.PubMedGoogle Scholar
  190. 176.
    Singh G, Scheithauer BW, Katyal S. The pathobiologic features of carcinomas of type II penumocytes. Cancer 1986; 57: 994–999.PubMedCrossRefGoogle Scholar
  191. 177.
    Hammar S, Bockus D, Remington F. Metastatic tumor of unknown origin. Ultrastruct Pathol 1986; 10: 281–288.PubMedCrossRefGoogle Scholar
  192. 178.
    Basset F, Soler P, Wyllie L, et al. Langerhans cells in a bronchioloalveolar tumor of lung. Virchow Arch [Pathol Anat] 1974; 362: 315–330.CrossRefGoogle Scholar
  193. 179.
    Hammar SP, Bockus D, Remington F, et al. Langerhans cells and serum precipitating antibodies against fungal antigen in bronchioloalveolar cell carcinomas; possible association with eosinophilic granuloma. Ultrastruct Pathol 1980; 1: 19–37.PubMedCrossRefGoogle Scholar
  194. 180.
    Hammar SP, Bockus D, Remington F, Bartha M. The widespread distribution of Langerhans cells in pathologic tissues: an ultrastructural and immunohistochemical study. Hum Pathol 1986; 17: 894–905.PubMedCrossRefGoogle Scholar
  195. 181.
    Takakura H, Hirohashi S, Shimosato Y, et al. Immunomorphologic responses of regional lymph nodes and prognosis in patients with stage I-A peripheral bronchial adenocarcinoma. Jpn J Cancer Clin 1983; 29: 777–785.Google Scholar
  196. 182.
    Furukawa T, Watanabe S, Kodoma T, Sato Y, Shimosato Y, Suemasu K. T-zone histiocytes in adenocarcinoma of lung in relation to postoperative prognosis. Cancer 1985; 56: 2651–2656.PubMedCrossRefGoogle Scholar
  197. 183.
    Hammar S. Adenocarcinoma and large cell undifferentiated carcinoma of the lung. Ultrastruct Pathol 1987; 11: 251–274.PubMedCrossRefGoogle Scholar
  198. 184.
    Barnes L. Intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Am J Surg Pathol 1986; 20: 192–202.CrossRefGoogle Scholar
  199. 185.
    Afzelius BA. Glycocalyx and glycocalyceal bodies in the respiratory epithelium of nose and bronchi. Ultrastruct Pathol 1984; 7: 1–8.PubMedCrossRefGoogle Scholar
  200. 186.
    Kodama T, Shimosato Y, Koide T, Watanabe S, Yoneyama T. Endobronchial polypoid adenocarcinoma of the lung: histologic and ultrastructural studies of five cases. Am J Surg Pathol 1984; 8: 845–854.PubMedCrossRefGoogle Scholar
  201. 187.
    Yousem SA, Hochholzer L. Alveolar adenoma. Hum Pathol 1986; 17: 1066–1071.PubMedCrossRefGoogle Scholar
  202. 188.
    Upton MP, Hirohashi S, Tome Y, Miyazawa N, Suemasu K, Shimosato Y. Expression of vimentin in surgically resected adenocarcinomas and large cell carcinomas of lung. Am J Surg Pathol 1986; 10: 560–567.PubMedCrossRefGoogle Scholar
  203. 189.
    Jasani B, Edwards RE, Thomas ND, Gibbs AR. The use of vimentin antibodies in the diagnosis of malignant mesothelioma. Virchows Arch [Pathol Anat] 1985; 406: 441–448.CrossRefGoogle Scholar
  204. 190.
    Cherwitz D, Swanson P, Drier J, Wick M. S100-protein reactivity in poorly differentiated carcinomas: an immunohistochemical comparison with malignant melanoma. Lab Invest 1987; 56: 13A.Google Scholar
  205. 191.
    Delmonte VC, Alberti O, Saldiva PHN. Large cell carcinoma of the lung: ultrastructural and immunohistochemical features. Chest 1986; 90: 524–527.PubMedCrossRefGoogle Scholar
  206. 192.
    Churg A. The fine structure of large cell undifferentiated carcinoma of the lung: evidence for its relation to squamous cell carcinomas and adenocarcinomas. Hum Pathol 1978; 9: 143–156.PubMedCrossRefGoogle Scholar
  207. 193.
    Horie A, Ohta M. Ultrastructural features of large cell carcinoma of the lung with reference to the prognosis in patients. Hum Pathol 1981; 12: 423 432.Google Scholar
  208. 194.
    Leong AS. The relevance of ultrastructural examination in the classification of primary lung tumors. Pathology 1982; 14: 37–46.PubMedCrossRefGoogle Scholar
  209. 195.
    Albain KS, True LD, Golomb HM, Hoffman PC, Little AG. Large cell carcinoma of the lung: ultrastructural differentiation and clinicopathologic correlations. Cancer 1985; 56: 1618–1623.PubMedCrossRefGoogle Scholar
  210. 196.
    Osborne BM, Mackay B, Butler JJ, Ordonez NG. Large cell lymphoma with microvilluslike projections: an ultra-structural study. Am J Clin Pathol 1983; 79: 443–450.PubMedGoogle Scholar
  211. 197.
    Gould VE, Chejfec G. Ultrastructural and biochemical analysis of pulmonary “undifferentiated” carcinomas. Hum Pathol 1978; 9: 377–384.PubMedCrossRefGoogle Scholar
  212. 198.
    McDowell EM, Wilson TS, Trump BF. Atypical endocrine tumors of the lung. Arch Pathol Lab Med 1981; 105: 20–28.PubMedGoogle Scholar
  213. 199.
    Hammond ME, Sause WT. Large cell neuroendocrine tumors of the lung: clinical significance and histopathologic definition. Cancer 1985; 56: 1624–1629.PubMedCrossRefGoogle Scholar
  214. 200.
    Neal MH, Kosinki R, Cohen P, Orenstein JM. Atypical endocrine tumors of the lung: a histologic, ultrastructural and clinical study of 19 cases. Hum Pathol 1986; 17: 1264–1277.PubMedCrossRefGoogle Scholar
  215. 201.
    Piehl MR, Lee I, Ma Y, et al. Subsets of pulmonary large cell undifferentiated carcinomas defined immunohistochemically. Lab Invest 1987; 56: 60A.Google Scholar
  216. 202.
    Nash G, Stout AP. Giant cell carcinoma of the lung: report of 5 cases. Cancer 1958; 11: 369–376.PubMedCrossRefGoogle Scholar
  217. 203.
    Ozzello L, Stout AP. The epithelial origin of giant cell carcinoma of the lung confirmed by tissue culture; report of a case. Cancer 1961; 14: 1052–1056.PubMedCrossRefGoogle Scholar
  218. 204.
    Wang NS, Seemayer TA, Ahmed MN, Knaack J. Giant cell carcinoma of the lung: a light and electron microscopic study. Hum Pathol 1976; 7: 3–16.PubMedCrossRefGoogle Scholar
  219. 205.
    Yesner R, Gerstl B, Auerbach O. Application of World Health Organization classification of lung carcinoma to biopsy material. Ann Thorac Surg 1965; 1: 33–49.CrossRefGoogle Scholar
  220. 206.
    Kern WH, Jones JC, Chapman ND. Pathology of bronchogenic carcinoma in long-term survivors. Cancer 1968; 21: 772–780.PubMedCrossRefGoogle Scholar
  221. 207.
    Auerbach O, Frasca JM, Parks VR, et al. A comparison of World Health Organization (WHO) classification of lung tumors by light and electron microscopy. Cancer 1982; 50: 2079–2088.PubMedCrossRefGoogle Scholar
  222. 208.
    Ashley DJ, Davies HD. Mixed glandular and squamouscell carcinoma of the bronchus. Thorax 1967; 22: 431–436.PubMedCrossRefGoogle Scholar
  223. 209.
    Fitzgibbons PL, Kern WH. Adenosquamous carcinoma of the lung: a clinical and pathologic study of seven cases. Hum Pathol 1985; 16: 463–466.PubMedCrossRefGoogle Scholar
  224. 210.
    McDowell EM, McLaughlin JS, Merenyl DK, et al. The respiratory epithelium. V. Histogenesis of lung carcindomas in the human. J Natl Cancer Inst 1978; 61: 587–606.PubMedGoogle Scholar
  225. 211.
    Wilson TS, McDowell EM, Trump BF. Immunohistochemical studies of keratinization in human lung tumors. J Cell Biol 1981; 91: 299a.Google Scholar
  226. 212.
    Feyrter F. Ueber diffuse endokrine epitheliale organe. Zentralbl inn Med 1938; 59: 545, 561.Google Scholar
  227. 213.
    Pearse AGE. The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic and pathologic implications of this concept. J Histochem Cytochem 1969; 17: 303–313.PubMedCrossRefGoogle Scholar
  228. 214.
    Pearse AGE, Takor Takor T. Embyrology of the diffuse neuroendocrine system and its relationship to the common peptides. Fed Proc 1979; 38: 2288–2294.PubMedGoogle Scholar
  229. 215.
    Pearse AGE. The diffuse neuroendocrine system: an extension of the APUD concept. In: Taylor S, ed. Endocrinology. London: Heinemann, 1972: 145.Google Scholar
  230. 216.
    Gould VE, DeLellis RA. The neuroendocrine cell system: its tumors, hyperplasias, and dysplasias. In: Silverberg SG, ed. Principles and practice of surgical pathology. New York: Wiley, 1983: 1488–1501.Google Scholar
  231. 217.
    Gould VE, Moll R, Moll I, Lee I, Franke WW. Neuroendocrine (Merkel) cells of the skin: hyperplasias dysplasias and neoplasms. Lab Invest 1985; 52: 334–353.PubMedGoogle Scholar
  232. 218.
    Gould VE, Linnoila RI, Memoli VA, Warren WH. Neu roendocrine components of the bronchopulmonary tract: hyperplasias, dysplasias, and neoplasms. Lab Invest 1983; 49: 519–537.PubMedGoogle Scholar
  233. 219.
    Gould VE, Wiedenmann B, Lee I, et al. Synaptophysin expression in neuroendocrine neoplasms as determined by immunocytochemistry. Am J Pathol 1987; 126: 243–257.PubMedGoogle Scholar
  234. 220.
    Hammar S, Gould VE. Neuroendocrine neoplasms. In: Azar HA, ed. Pathology of human neoplasms: an atlas of diagnostic electron microscopy and immunohistochemistry. New York: Raven Press, 1987 (in press).Google Scholar
  235. 221.
    Haimoto H, Takahashi Y, Koshikawa T, Nagura H, Kato K. Immunohistochemical localization of y-enolase in normal human tissues other than nervous and neuroendocrine tissues. Lab Invest 1985; 52: 257–263.PubMedGoogle Scholar
  236. 222.
    Pahlman S, Esscher T, Nilsson K. Expression of -y-subunit of enolase, neuron-specific enolase in human nonneuroendocrine tumors and derived cell lines. Lab Invest 1986; 54: 554–560.PubMedGoogle Scholar
  237. 223.
    Vinores SA, Bonnin JM, Rubinstein LJ, Marangos PJ. Immunohistochemical demonstration of neuron-specific enolase in neoplasms of the CNS and other tissues. Arch Pathol Lab Med 1984; 120: 186–192.Google Scholar
  238. 224.
    Bergh J, Escher T, Steinholtz L, Nilsson K, Pahlman S. Immunocytochemical demonstration of neuron-specific enolase (NSE) in human lung cancers. Am J Clin Pathol 1985; 84: 1–7.PubMedGoogle Scholar
  239. 225.
    Said JW, Vimadalal S, Nash G, et al. Immunoreactive neuron-specific enolase, bombesin, and chromogranin as markers for neuroendocrine lung tumors. Hum Pathol 1985; 16: 236–240.PubMedCrossRefGoogle Scholar
  240. 226.
    Schmechel DE. ‘y-subunit of the glycolytic enzyme enolase: nonspecific or neuron specific? Lab Invest 1985;52:239–242.Google Scholar
  241. 227.
    O’Connor DT, Burton D, Deftos LJ. Immunoreactive human chromogranin A in diverse polypeptide hormone producing human tumors and normal endocrine tissues. J Clin Endocrinol Metab 1983; 57: 1084–1086.PubMedCrossRefGoogle Scholar
  242. 228.
    Lloyd RV, Wilson BS, Kovacs K, Ryan N. Immunohistochemical localization of chromogranin in human hypophyses and pituitary adenomas. Arch Pathol Lab Med 1985; 109: 515–517.PubMedGoogle Scholar
  243. 229.
    McNutt MA, Bolen JW. Adenomatous tumor of the middle ear. Am J Clin Pathol 1985; 84: 541–547.PubMedGoogle Scholar
  244. 230.
    Bussolati G, Gugliotta P, Sapino A, Eusebi V, Lloyd R. Chromogranin-reactive endocrine cells in argyrophilic carcinomas (“carcinoids”) from normal tissue of the breast. Am J Pathol 1985; 120: 186–192.PubMedGoogle Scholar
  245. 231.
    O’Connor DT, Deftos U. Secretion of chromogranin A by peptide-producing endocrine neoplasms. N Engl J Med 1986; 314: 1145–1151.PubMedCrossRefGoogle Scholar
  246. 232.
    Lloyd RV, Sisson JC, Shapiro B, Verhofstad AAJ. Immunohistochemical localization of epinephrine, norepinephrine, catecholamine-synthesizing enzymes and chromogranin in neuroendocrine cells and tumors. Am J Pathol 1986; 125: 45–54.PubMedGoogle Scholar
  247. 233.
    Banks P, Helle K. The release of protein from the stimulated adrenal medulla. Biochem J 1965; 97: 40C - 41C.PubMedGoogle Scholar
  248. 234.
    Angeletti RH. Chromogranins and neuroendocrine secretion. Lab Invest 1986; 55: 387–390.PubMedGoogle Scholar
  249. 235.
    Jahn B, Schibler W, Ouimet C, et al. A 38,000 dalton membrane protein (p38) present in synaptic vesicles. Proc Natl Acad Sci USA 1985; 82: 4137–4141.PubMedCrossRefGoogle Scholar
  250. 236.
    Gould VE, Lee I, Wiedenmann B, Moll R, Chejfec G, Franke WW. Synaptophysin: a novel marker for neurons, certain neuroendocrine cells and their neoplasms. Hum Pathol 1986; 17: 979–983.PubMedCrossRefGoogle Scholar
  251. 237.
    Kahn HJ, Garrido A, Huang S-N, Baumal R. Intermediate filaments and tumor diagnosis. Lab Invest 1983; 49: 509.Google Scholar
  252. 238.
    Lehto V-P, Stenman S, Miettinen M, Dahl D, Virtanen I. Expression of a neural type of intermediate filament as a distinguishing feature between oat cell carcinoma and other lung cancers. Am J Pathol 1983; 110: 113–118.PubMedGoogle Scholar
  253. 239.
    VanMuijen GNP, Ruiter DJ, Leeuwen CV, Prins FA, Rietsema K, Warnaar SO. Cytokeratin and neurofilament in lung carcinomas. Am J Pathol 1984; 116: 363–369.Google Scholar
  254. 240.
    Lehto V-P, Miettinen M, Dahl D, Virtanen I. Bronchial carcinoid cells contain neural-type intermediate filaments. Cancer 1984; 54: 624–628.PubMedCrossRefGoogle Scholar
  255. 241.
    Clark RK, Miettinen M, Leij L, Damjanov I. Terminally differentiated derivatives of pulmonary small cell carcinomas may contain neurofilaments. Lab Invest 1985; 53: 243–244.PubMedGoogle Scholar
  256. 242.
    Broers J, Huysmans A, Moesker O, Vooijs P, Ramaekers F, Wagenaar S. Small cell lung cancer contains intermediate filaments of the cytokeratin type. Lab Invest 1985; 52: 113–114.PubMedGoogle Scholar
  257. 243.
    Moll R, Franke WW, Schiller DL, et al. The catalogue of human cytokeratins. Patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982; 31: 1124.CrossRefGoogle Scholar
  258. 244.
    Cooper D, Schermer A, Sun T-T. Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: strategies, applications and limitations. Lab Invest 1985; 52: 243–256.PubMedGoogle Scholar
  259. 245.
    Gown AM, Gabbiani G. Intermediate-sized (10-nm) filaments in human tumors. In: DeLellis, RA, ed. Advances in immunohistochemistry. New York: Masson, 1984: 89–109.Google Scholar
  260. 246.
    Miettinen M, Lehto V-P, Virtanen I. Antibodies to intermediate filament proteins in the diagnosis and classification of human tumors. Ultrastruct Pathol 1984; 7: 83107.CrossRefGoogle Scholar
  261. 247.
    Moll R, Cowin P, Kapprell H-P, Franke WW. Desmosomal proteins: new markers for identification and classification of tumors. Lab Invest 1986; 54: 4–25.PubMedGoogle Scholar
  262. 248.
    Bunn P, Linnoila I, Minna J, Carney D, Gazdar AF. Small-cell lung cancer, endocrine cells of the fetal bronchus and other neuroendocrine cells express Leu-7 antigenic determinant present on natural killer cells. Blood 1985; 65: 764–768.PubMedGoogle Scholar
  263. 249.
    Funa K, Gazdar AF, Minna JD, Linnoila RI. Paucity of B2-microglobulin expression on small cell lung cancer, bronchial carcinoids, and certain other neuroendocrine tumors. Lab Invest 1986; 55: 186–192.PubMedGoogle Scholar
  264. 250.
    Payne CM, Nagle RB, Borduin V. Methods in laboratory investigation: an ultrastructural cytochemical stain specific for neuroendocrine neoplasms. Lab Invest 1984; 51: 350–365.PubMedGoogle Scholar
  265. 251.
    Nagle RB, Payne CM, Clark VA. Comparison of the usefulness of histochemistry and ultrastructural cytochemistry in the identification of neuroendocrine neoplasms. Am J Clin Pathol 1986; 85: 289–296.PubMedGoogle Scholar
  266. 252.
    Gould VE, Benditt EP. Ultrastructural and functional relationships of some human endocrine tumors. Pathol Annu 1973; 8: 205–230.PubMedGoogle Scholar
  267. 253.
    Gould VE. Neuroendocrinomas and neuroendocrine carcinomas: APUD-cell system neoplasms and their aberrant secretory activities. Pathol Annu 1977; 12 (Part 2): 33–62.Google Scholar
  268. 254.
    Fröhlich F. Die ‘Helle Zelle’ der Bronchialschleimhaut und ihre Beziehungen zum Problem der Chemoreceptoren. Frankfurt Ztschr Z Pathol 1949; 60: 517–559.Google Scholar
  269. 255.
    Feyrter F. Zur Pathologie des argyrophilen Helle-ZellOrganes im Bronchialbaum des Menschen. Virchows Arch 1954; 325: 723–732.PubMedCrossRefGoogle Scholar
  270. 256.
    Bensch KG, Gordon GB, Miller LR. Studies on the bronchial counterpart of the Kultschitzky (argentaffin) cell and innervation of bronchial glands. J Ultrastruct Res 1965; 12: 668–686.PubMedCrossRefGoogle Scholar
  271. 257.
    Bensch KG, Gordon GB, Miller LR. Electron microscopic and biochemical studies on the bronchial carcinoid tumor. Cancer 1965; 18: 592–602.PubMedCrossRefGoogle Scholar
  272. 258.
    Gmelich JT, Bensch KG, Liebow AA. Cells of Kultchitzky type in bronchioles and their relation to the origin of peripheral carcinoid tumor. Lab Invest 1967; 17: 88–98.PubMedGoogle Scholar
  273. 259.
    Lauweryns JM, Cokelaere M, Theunynck PK. Neuro-epithelial bodies in the respiratory mucosa of various mammals: a light optical, histochemical, and ultrastructural investigation. Z Zellforsch Mikrosk Anat 1972; 135: 569–592.PubMedCrossRefGoogle Scholar
  274. 260.
    Lauweryns JM, Goddeeris P. Neuroepithelial bodies in the human child and adult lung. Am Rev Respir Dis 1975; 111: 469–476.PubMedGoogle Scholar
  275. 261.
    Whitwell F. Tumorlets of the lung. J Pathol Bacteriol 1955; 70: 529–541.PubMedCrossRefGoogle Scholar
  276. 262.
    D’Aggti VD, Perzin KH. Carcinoid tumorlets of the lung with metastasis to a peribronchial lymph node: report of a case and review of the literature. Cancer 1985; 55: 2472–2476.CrossRefGoogle Scholar
  277. 263.
    Mueller H. Zur Untersuchungsgeschichte der bronchialen Weiterungen. Inaug Diss Halle, 1882.Google Scholar
  278. 264.
    Kramer R. Adenoma of bronchus. Ann Otol Rhinol Laryngol 1930; 39: 689–695.Google Scholar
  279. 265.
    Hamperl H. Über gutartige Bronchialtumoren. Virchows Arch [Pathol Anat] 1937; 300: 1937: 46–88.Google Scholar
  280. 266.
    Oberndorfer S. Karzinoide Tumoren des Dünndarms. Frankfurt Zeitschr Pathol 1907; 1: 426–432.Google Scholar
  281. 267.
    Briselli M, Mark GJ, Grillo HC. Tracheal carcinoids. Cancer 1978; 42: 2870–2879.PubMedCrossRefGoogle Scholar
  282. 268.
    Bonikos DS, Bensch KG, Jamplis RW. Peripheral pulmonary carcinoid tumors. Cancer 1976; 37: 1977–1998.PubMedCrossRefGoogle Scholar
  283. 269.
    Felton WL, Liebow AA, Lindskog GE. Peripheral and multiple bronchial adenomas. Cancer 1953; 6: 555–567.PubMedCrossRefGoogle Scholar
  284. 270.
    Skinner C, Ewen SWB. Carcinoid lung: diffuse pulmonary infiltration by a multifocal bronchial carcinoid. Thorax 1976; 31: 212–219.PubMedCrossRefGoogle Scholar
  285. 271.
    Carter D, Eggleston JC. Carcinoid tumors. In: Tumors of the lower respiratory tract. Atlas of tumor pathology, 2d ser., fasc. 17. Washington DC: Armed Forces Institute of Pathology, 1980: 162–188.Google Scholar
  286. 272.
    Mark EJ, Quay SC, Dickensin GR. Papillary carcinoid tumor of the lung. Cancer 1981; 48: 316–324.PubMedCrossRefGoogle Scholar
  287. 273.
    Sklar JL, Churg A, Bensch KG. Oncocytic carcinoid tumor of the lung. Am J Surg Pathol 1980; 4: 287–292.PubMedCrossRefGoogle Scholar
  288. 274.
    Sajjad SM, Mackay B, Lukeman JM. Oncocytic carcinoid tumor of the lung. Ultrastruct Pathol 1980; 1: 171–176.PubMedCrossRefGoogle Scholar
  289. 275.
    Scharifker D, Marchevsky A. Oncocytic carcinoid of lung: an ultrastructural analysis. Cancer 1981; 47: 530–532.PubMedCrossRefGoogle Scholar
  290. 276.
    Ghadially FN, Block HJ. Oncocytic carcinoid of the lung. J Submicrosc Cytol 1985; 17: 435–442.PubMedGoogle Scholar
  291. 277.
    Santos-Briz, Terron J, Sastre R, Romero L, Valle A. Oncocytoma of the lung. Cancer 1977; 40: 1330–1336.CrossRefGoogle Scholar
  292. 278.
    Cebelin MS. Melanocytic bronchial carcinoid tumor. Cancer 1980; 46: 1843–1848.PubMedCrossRefGoogle Scholar
  293. 279.
    Grazer R, Cohen SM, Jacobs JB, Lucas P. Melanin-containing peripheral carcinoid of the lung. Am J Surg Pathol 1982; 6: 73–78.PubMedCrossRefGoogle Scholar
  294. 280.
    Arrigoni MG, Woolner LB, Bernatz PE. Atypical carcinoid tumors of the lung. J Thorac Cardiovasc Surg 1972; 64: 413–421.PubMedGoogle Scholar
  295. 281.
    Leschke H. Über nur regionär bösartige and über krebsig entartete Bronchusadenome bzw. Carcinoide. Virchows Arch [Path Anat] 1956; 328: 635–657.Google Scholar
  296. 282.
    Warren WH, Memoli VA, Gould VE. Immunohistochemical and ultrastructural analysis of bronchopulmonary neuroendocrine neoplasms. II. Well-differentiated neuroendocrine carcinomas. Ultrastruct Pathol 1984; 7: 185–199.PubMedCrossRefGoogle Scholar
  297. 283.
    Mark EJ, Ramirez JF. Peripheral small-cell carcinoma of the lung resembling carcinoid tumor: a clinical and pathologic study of 14 cases. Arch Pathol Lab Med 1985; 109: 263–269.PubMedGoogle Scholar
  298. 284.
    Paladugu RR, Benfield JR, Pak HY, Ross RK, Teplitz RL. Bronchopulmonary kulchitzky cell carcinomas. Cancer 1985; 55: 1303–1311.PubMedCrossRefGoogle Scholar
  299. 285.
    Bernard WG. The nature of the “oat-celled sarcoma” of the mediastinum. J Pathol Bacteriol 1926; 29: 241–244.CrossRefGoogle Scholar
  300. 286.
    Gibbon JH Jr, Nealon TF Jr. Neoplasms of the lungs and trachea. In: Gibbon JH Jr, ed. Surgery of the chest. Philadelphia: Saunders, 1962: 484.Google Scholar
  301. 287.
    Azzopardi JG. Oat-cell carcinoma of the bronchus. J Pathol Bacteriol 1959; 78: 513–519.PubMedCrossRefGoogle Scholar
  302. 288.
    Yesner R. Small cell tumors of the lung. Am J Surg Pathol 1983; 7: 775–785.PubMedGoogle Scholar
  303. 289.
    Carter D. Small-cell carcinoma of the lung. Am J Surg Pathol 1983; 7: 787–795.PubMedGoogle Scholar
  304. 290.
    Yesner R. Classification of long-cancer histology. N Engl J Med 1985; 312: 652–653.PubMedGoogle Scholar
  305. 291.
    Gazdar AF, Carney DN, Baylin SB, et al. Small cell carcinoma of the lung. Altered morphological, biological and biochemical characteristics in long term cultures and heterotransplanted tumors. Proc Am Assoc Cancer Res 1980; 21: 51.Google Scholar
  306. 292.
    Abrams HJ, Spiro R, Goldstein N. Metastases in carcinoma, analysis of 1000 autopsied cases. Cancer 1950; 3: 74–85.PubMedCrossRefGoogle Scholar
  307. 293.
    Rosenblatt MB, Lisa JR, Trinidad S. Pitfalls in the clinical and histological diagnosis of bronchogenic carcinoma. Dis Chest 1966; 49: 396–404.PubMedCrossRefGoogle Scholar
  308. 294.
    Willis RA. The spread of tumours in the human body. London: Butterworths, 1973: 167–174.Google Scholar
  309. 295.
    Braman SS, Whitcomb ME. Endobronchial metastasis. Arch Intern Med 1975; 135: 543–547.PubMedCrossRefGoogle Scholar
  310. 296.
    Farrell JT Jr. Pulmonary metastasis: a pathologic, clinical, roentgenologic study based on 78 cases seen at necropsy. Radiology 1935; 24: 444–451.Google Scholar
  311. 297.
    Seiler HH, Clagett T, McDonald JR. Pulmonary resection for metastatic malignant lesions. J Thorac Surg 1950; 19: 655–679.PubMedGoogle Scholar
  312. 298.
    Fitzgerald RH. Endobronchial metastases. South Med J 1977; 79: 440–443.CrossRefGoogle Scholar
  313. 299.
    King DS, Castleman B. Bronchial involvement in metastatic pulmonary malignancy. J Thorac Surg 1943; 12: 305–315.Google Scholar
  314. 300.
    Garces M, Tsai E, Marsan RE. Endotracheal metastases. Chest 1974; 65: 350–351.PubMedCrossRefGoogle Scholar
  315. 301.
    Winterbauer RH, Elfenbein IB, Ball WC Jr. Incidence and clinical significance of tumor embolization to the lungs. Am J Med 1968; 45: 271–290.PubMedCrossRefGoogle Scholar
  316. 302.
    Hughes JE. A case of hydatidiform mole with multiple small syncytial infarctions of the lungs. Proc R Soc Med 1930; 23: 33–35.Google Scholar
  317. 303.
    Gonzalez-Vitale JC, Garcia-Bunuel R. Pulmonary tumor emboli and cor pulmonale in primary carcinoma of the lung. Cancer 1976; 38: 2105–2110.PubMedCrossRefGoogle Scholar
  318. 304.
    Schmidt MB. Die Verbreitungswege der Karzinome and die Beziehung generalisierter Sarkome zu den leukämischen Neubildungen. Jena 1903, as quoted by Saphir.308Google Scholar
  319. 305.
    Takahashi M. An experimental study of metastasis. J Pathol Bacteriol 1915; 20: 1–13.CrossRefGoogle Scholar
  320. 306.
    Iwasaki T. Histological and experimental observations on the destruction of tumor cells in the blood vessels. J Pathol Bacteriol 1915–16; 20: 85–105.Google Scholar
  321. 307.
    Warren S, Gates O. The fate of intravenously injected tumor cells. Am J Cancer 1936; 27: 485–492.Google Scholar
  322. 308.
    Saphir O. The fate of carcinoma emboli in the lung. Am J Pathol 1947; 23: 245–253.PubMedGoogle Scholar
  323. 309.
    Aabo K, Hansen KB. Megakaryocytes in pulmonary blood vessels. Acta Path Microbiol Scand [A] 1978; 86: 285–291.Google Scholar
  324. 310.
    Yang SP, Lin CC. Lymphangitic carcinomatosis of the lungs: the clinical significance of its roentgenologic classification. Chest 1972; 62: 179–187.PubMedCrossRefGoogle Scholar
  325. 311.
    Goldsmith HS, Bailey HD, Callahan EL, Beattie EJ Jr. Pulmonary lymphangitic metastases from breast cancer. Arch Surg 1967; 94: 483–488.PubMedCrossRefGoogle Scholar
  326. 312.
    Thurlbeck WM. Neoplasia of the pulmonary vascular bed. In: Moser KM, ed. Pulmonary vascular disease. 845 New York: Marcel Dekker, 1979: 629–649.Google Scholar
  327. 313.
    Schimmel DH, Julien PJ, Gamsu G. Resolution of pulmonary lymphangitic carcinoma of the breast. Chest 1976; 69: 106–108.PubMedCrossRefGoogle Scholar
  328. 314.
    Morgan AD. The pathology of subacute cor pulmonale in diffuse carcinomatosis of the lungs. J Pathol Bacteriol 1959; 61: 75–84.CrossRefGoogle Scholar
  329. 315.
    Janower ML, Blennerhassett JB. Lymphangitic spread of metastatic cancer to the lung: a radiologic-pathologic classification. Radiology 1971; 101: 267–273.PubMedGoogle Scholar
  330. 316.
    Chute CG, Greenberg ER, Baron J, Korson R, Baker J, Yates J. Presenting conditions of 1539 population-based lung cancer patients by cell type and stage in New Hampshire and Vermont. Cancer 1985; 56: 2107–2111.PubMedCrossRefGoogle Scholar
  331. 317.
    Andersen HA, Bernatz PE. Extrathoracic manifestations of bronchogenic carcinoma. Med Clin N Am 1964; 48: 921–931.PubMedGoogle Scholar
  332. 318.
    Mountain CF, Lukeman JM, Hammar S, et al. Lung cancer classification: the relationship of disease extent and cell type to survival in a trial population. J Surg Oncol (in press).Google Scholar
  333. 319.
    Okike N, Bernatz PE, Woolner LB. Carcinoid tumors of the lung. Ann Thorac Surg 1976; 22: 270–275.PubMedCrossRefGoogle Scholar
  334. 320.
    Brandt B, Heintz SE, Rose EF, Ehrenhaft JL. Bronchial carcinoid tumors. Ann Thorac Surg 1984; 38: 63–65.PubMedCrossRefGoogle Scholar
  335. 321.
    McCaughan BC, Martini N, Bains MS. Bronchial carcinoids: review of 124 cases. J Thorac Cardiovasc Surg 1985; 89: 8–17.PubMedGoogle Scholar
  336. 322.
    Copple B, Wright SE, Moatamed F. Electron microscopy in small cell lung carcinomas: clinical correlation. J Clin Oncol 1984; 2: 910–916.PubMedGoogle Scholar
  337. 323.
    Vollmer RT, Shelburne JD, Iglehart JD. Intercellular junctions and tumor stage in small cell carcinoma of the lung. Hum Pathol 1986; 18: 22–27.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1988

Authors and Affiliations

  • Samuel P. Hammar

There are no affiliations available

Personalised recommendations